Financhill
Back

Avidity Biosciences Quote, Financials, Valuation and Earnings

Avidity Biosciences Price Quote

$25.41
-0.92 (-3.49%)
(Updated: May 7, 2024 at 3:50 PM ET)

Avidity Biosciences Key Stats

Buy
55
Avidity Biosciences (RNA) is a Buy

Day range:
$25.74 - $26.85
52-week range:
$4.83 - $27.66
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
201.06
P/B ratio:
4.19%

Volume:
505K
Avg. volume:
971.7K
1-year change:
127.37%
Market cap:
$2.1B
Revenue:
$9.6M
EPS:
$-2.91

How Much Does Avidity Biosciences Make?

Is Avidity Biosciences Growing As A Company?

  • What Is Avidity Biosciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.21%
  • What Is Avidity Biosciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Avidity Biosciences Stock Price Performance

What Is Avidity Biosciences 52-Week High & Low?

Avidity Biosciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Avidity Biosciences?

Is Avidity Biosciences Cash Flow Positive?

  • What Is RNA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$119.1M
  • What Is Avidity Biosciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $93.9M
  • What Is Avidity Biosciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$130.1M

Avidity Biosciences Return On Invested Capital

  • Is Management Doing A Good Job?
    RNA return on invested capital is -39.09%
  • What Is Avidity Biosciences Return On Assets?
    ROA measures how assets are converting to revenues and is -34.62%
  • What Is RNA Return On Equity?
    ROE is a measure of profitability and is -39.09%

Avidity Biosciences Earnings Date & Stock Price

Avidity Biosciences Competitors

Avidity Biosciences Dividend Yield

Data Unavailable

Avidity Biosciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -25%
Revenue: -20.8% -82.04%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 45.88
Upside from Last Price: 74.23%

Major Shareholders

  • How many RNA shares are owned by institutional investors?
    145.8M RNA shares are owned by institutional investors
  • How many RNA shares are owned by insiders?
    286.7K RNA shares are owned by insiders